Vivek Nagaraja

700 total citations
23 papers, 459 citations indexed

About

Vivek Nagaraja is a scholar working on Pathology and Forensic Medicine, Pulmonary and Respiratory Medicine and Immunology. According to data from OpenAlex, Vivek Nagaraja has authored 23 papers receiving a total of 459 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Pathology and Forensic Medicine, 9 papers in Pulmonary and Respiratory Medicine and 6 papers in Immunology. Recurrent topics in Vivek Nagaraja's work include Systemic Sclerosis and Related Diseases (17 papers), Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (8 papers) and Mast cells and histamine (5 papers). Vivek Nagaraja is often cited by papers focused on Systemic Sclerosis and Related Diseases (17 papers), Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (8 papers) and Mast cells and histamine (5 papers). Vivek Nagaraja collaborates with scholars based in United States, United Kingdom and Italy. Vivek Nagaraja's co-authors include Dinesh Khanna, Terri Getzug, Zsuzsanna H. McMahan, Christopher P. Denton, Mark Pimentel, Heather Gladue, Daniel E. Furst, Tracy Frech, William D. Chey and Philip J. Clements and has published in prestigious journals such as SHILAP Revista de lepidopterología, Annals of the Rheumatic Diseases and Journal of Medical Internet Research.

In The Last Decade

Vivek Nagaraja

22 papers receiving 455 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Vivek Nagaraja United States 11 340 158 96 90 84 23 459
Predrag Ostojić Serbia 13 319 0.9× 119 0.8× 124 1.3× 51 0.6× 100 1.2× 31 428
Rebecca Matro United States 10 140 0.4× 132 0.8× 37 0.4× 171 1.9× 53 0.6× 19 530
Amber Young United States 11 259 0.8× 178 1.1× 66 0.7× 19 0.2× 91 1.1× 13 364
Antoine Giraud France 9 97 0.3× 302 1.9× 16 0.2× 34 0.4× 56 0.7× 43 511
Véronique Le-Guern France 7 260 0.8× 79 0.5× 141 1.5× 55 0.6× 132 1.6× 7 364
Chiara M. Antonioli Italy 8 172 0.5× 61 0.4× 69 0.7× 42 0.5× 60 0.7× 13 299
Meena Kalluri Canada 15 71 0.2× 499 3.2× 22 0.2× 50 0.6× 220 2.6× 44 690
Mandel Sher United States 11 19 0.1× 298 1.9× 35 0.4× 107 1.2× 97 1.2× 40 581
Wilma C. Diner United States 11 123 0.4× 130 0.8× 18 0.2× 261 2.9× 29 0.3× 22 493
Lara Dani Sweden 11 19 0.1× 34 0.2× 50 0.5× 33 0.4× 171 2.0× 20 355

Countries citing papers authored by Vivek Nagaraja

Since Specialization
Citations

This map shows the geographic impact of Vivek Nagaraja's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Vivek Nagaraja with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Vivek Nagaraja more than expected).

Fields of papers citing papers by Vivek Nagaraja

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Vivek Nagaraja. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Vivek Nagaraja. The network helps show where Vivek Nagaraja may publish in the future.

Co-authorship network of co-authors of Vivek Nagaraja

This figure shows the co-authorship network connecting the top 25 collaborators of Vivek Nagaraja. A scholar is included among the top collaborators of Vivek Nagaraja based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Vivek Nagaraja. Vivek Nagaraja is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Paul, Margaret M., Nandita Khera, Musab S. Hommos, et al.. (2025). The State of Remote Patient Monitoring for Chronic Disease Management in the United States. Journal of Medical Internet Research. 27. e70422–e70422. 1 indexed citations
2.
Melville, David M., et al.. (2025). Peripheral Spondyloarthritis: Conceptualization and Diagnosis as a Distinct Rheumatologic Subset of Disease. Seminars in Musculoskeletal Radiology. 29(2). 236–248. 1 indexed citations
3.
Eshak, Nouran, et al.. (2025). The Effectiveness of Sacubitril/Valsartan in Systemic Sclerosis Patients with Heart Failure: A Retrospective Analysis. Journal of Clinical Medicine. 14(12). 4054–4054.
4.
Nagaraja, Vivek, et al.. (2024). Interstitial lung disease in autoimmune diseases. Revista Colombiana de Reumatología. 31. S139–S153. 1 indexed citations
5.
Jokerst, Clinton, Kavitha Yaddanapudi, Sachin Chaudhary, Ana Zamora, & Vivek Nagaraja. (2024). Imaging Innovations in the Screening, Diagnosis, and Monitoring of Systemic Autoimmune Disease-Related Interstitial Lung Disease. SHILAP Revista de lepidopterología. 71–81. 2 indexed citations
6.
Nagaraja, Vivek, et al.. (2024). Interstitial lung disease in autoimmune diseases. Revista Colombiana de Reumatología (English Edition). 31. S139–S153. 1 indexed citations
7.
Makol, Ashima, et al.. (2023). Recent innovations in the screening and diagnosis of systemic sclerosis-associated interstitial lung disease. Expert Review of Clinical Immunology. 19(6). 613–626. 9 indexed citations
8.
Khanna, Dinesh, Cristina M. Padilla, Lam C. Tsoi, et al.. (2022). Tofacitinib blocks IFN-regulated biomarker genes in skin fibroblasts and keratinocytes in a systemic sclerosis trial. JCI Insight. 7(17). 42 indexed citations
9.
Nagaraja, Vivek, Marco Matucci‐Cerinic, Daniel E. Furst, et al.. (2020). Current and Future Outlook on Disease Modification and Defining Low Disease Activity in Systemic Sclerosis. Arthritis & Rheumatology. 72(7). 1049–1058. 28 indexed citations
10.
Nagaraja, Vivek. (2019). Management of scleroderma renal crisis. Current Opinion in Rheumatology. 31(3). 223–230. 22 indexed citations
11.
Namas, Rajaie, Sara Jaafar, Holly Wilhalme, et al.. (2019). Reliability, construct validity and responsiveness to change of the PROMIS-29 in systemic sclerosis-associated interstitial lung disease.. PubMed. 37 Suppl 119(4). 49–56. 11 indexed citations
12.
Pauling, John D, Vivek Nagaraja, & Dinesh Khanna. (2019). Insight into the Contrasting Findings of Therapeutic Trials of Digital Ischaemic Manifestations of Systemic Sclerosis. 5(2). 85–103. 7 indexed citations
13.
Nagaraja, Vivek, et al.. (2018). The role of the dermatologist in Raynaud's phenomenon: a clinical challenge. Journal of the European Academy of Dermatology and Venereology. 32(7). 1120–1127. 10 indexed citations
14.
Nagaraja, Vivek, Constance A. Mara, Puja Khanna, et al.. (2017). Establishing clinical severity for PROMIS® measures in adult patients with rheumatic diseases. Quality of Life Research. 27(3). 755–764. 44 indexed citations
15.
McCoy, Sara S., et al.. (2015). Exacerbation of Psoriasis due to Hydroxychloroquine. 7(3). 3 indexed citations
16.
Nagaraja, Vivek, Zsuzsanna H. McMahan, Terri Getzug, & Dinesh Khanna. (2015). Management of Gastrointestinal Involvement in Scleroderma. PubMed. 1(1). 82–105. 60 indexed citations
17.
18.
Nagaraja, Vivek, Christopher P. Denton, & Dinesh Khanna. (2014). Old medications and new targeted therapies in systemic sclerosis. Lara D. Veeken. 54(11). 1944–1953. 36 indexed citations
19.
Khanna, Dinesh, Vivek Nagaraja, Heather Gladue, et al.. (2013). Measuring response in the gastrointestinal tract in systemic sclerosis. Current Opinion in Rheumatology. 25(6). 700–706. 55 indexed citations
20.
Nagaraja, Vivek, et al.. (2010). Pulmonary Embolism Mimicking Pneumonia in a HIV Patient. Case Reports in Medicine. 2010. 1–3. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Predrag Ostojić Breakdown of academic impact, for papers by Rebecca Matro Breakdown of academic impact, for papers by Amber Young Breakdown of academic impact, for papers by Antoine Giraud Breakdown of academic impact, for papers by Véronique Le-Guern Breakdown of academic impact, for papers by Chiara M. Antonioli Breakdown of academic impact, for papers by Meena Kalluri Breakdown of academic impact, for papers by Mandel Sher Breakdown of academic impact, for papers by Wilma C. Diner Breakdown of academic impact, for papers by Lara Dani
Rankless by CCL
2026